Medtronic is cutting its fourth quarter earnings guidance as it absorbs research and development costs for a new insulin pump ...
MiniMed, the insulin pump company that was born in Northridge and later folded into Medtronic, has officially come full ...
Medtronic (MDT) has cut its full-year earnings outlook, citing the recent IPO of its diabetes business, MiniMed Group (MMED), and the earlier-than-expected FDA approval and commercial launch of ...
MiniMed Group Inc. is back as a locally based publicly traded company, having come full circle after 30 years. The Northridge ...
MiniMed Flex is a smartphone-controlled insulin pump about half the size of MiniMed’s previous device. It’s the company’s ...
MiniMed, the recently spun-out diabetes business of Medtronic, has received FDA clearance for its MiniMed Flex insulin pump.
The latest announcement is out from Medtronic ( (MDT) ).
MiniMed is out to prove it deserves the name, with a new FDA clearance for its smallest insulin pump yet. | At about half ...
Medtronic reduces full-year earnings guidance following MiniMed Group IPO and one-time charge tied to Blackstone payments.
Medtronic (NYSE:MDT) said in an SEC filing that it lowered its 2026 guidance after a one-time charge related to its MiniMed ...
Under the terms of the merger agreement, Merck, through a subsidiary, will acquire all of the outstanding shares of Terns. As a result of the IPO, the company projects a total dilutive effect of $0.04 ...
The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results